- Trials with a EudraCT protocol (114)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
114 result(s) found for: Pulmonary Insufficiency.
Displaying page 1 of 6.
EudraCT Number: 2008-000102-36 | Sponsor Protocol Number: Everopolm | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: Immunosoppressive protocol based on everolimus and calcineurin inhibitor low doses in lung transplant recipients with moderate-severe kidney disease after standard immnuotherapy. | |||||||||||||
Medical condition: kidney disease after pulmonary transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005014-30 | Sponsor Protocol Number: AlproECMO_1.0 | Start Date*: 2016-06-02 | ||||||||||||||||
Sponsor Name:Medical University of Vienna, Department of Internal medicine I | ||||||||||||||||||
Full Title: A prospective randomized, double blind study on safety and efficacy of Alprostadil as additional Anticoagulant in Patients with veno- venous ECMO | ||||||||||||||||||
Medical condition: pulmonary insufficiency, which cannot be treated with measures of mechanical ventilation alone, Conditions in which veno-venous extracorporeal membrane oxygenation therapy is indicated | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-003461-41 | Sponsor Protocol Number: HP4.3 | Start Date*: 2007-11-13 |
Sponsor Name:Deutsche Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler | ||
Full Title: Cardiac imaging under dobutamine stress for early assessment of right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation | ||
Medical condition: Fallot tetralogy late after repair with marked pulmonary valve incompetence | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002367-34 | Sponsor Protocol Number: 29052016 | Start Date*: 2016-09-30 | |||||||||||
Sponsor Name:Hjertemedicinsk klinik, Rigshospitalet | |||||||||||||
Full Title: Beta 3 agonist treatment in heart failure (BEAT-HF II) | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020516-11 | Sponsor Protocol Number: CRCFC-DHA002 | Start Date*: 2010-09-16 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA | ||||||||||||||||||
Full Title: EXPERIMENTAL STUDY, RANDOMIZED, OPEN LABEL, TO EVALUATE THE EFFECT OF DOCOSAHEXAENOIC ACID (DHA) SUPPLEMENTATION VERSUS 5-METHYLTETHRAHYDROFOLATE + B12 VITAMIN AND DHA, IN CYSTIC FIBROSIS PATIENTS ... | ||||||||||||||||||
Medical condition: CYSTIC FIBROSIS AND PANCREATIC INSUFFICIENCY | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001325-31 | Sponsor Protocol Number: NL73551.091.20 | Start Date*: 2020-05-20 | |||||||||||||||||||||
Sponsor Name:Radboud University Medical Center | |||||||||||||||||||||||
Full Title: [68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of activated endothelium in lung parenchyma of COVID-19 patients. | |||||||||||||||||||||||
Medical condition: Maximum 10 patients from the Infectious Diseases ward with proven COVID-19 infection and pulmonary abnormalities on contrast-enhanced CT undergo static PET scans after injection of 70 μg (200 MBq) ... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-001779-31 | Sponsor Protocol Number: FONDAPARINUX | Start Date*: 2008-05-09 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI | |||||||||||||
Full Title: Markers of hypercoagulability and risk of death and rehospitalization in heart failure patients: a pilot study on the effects of Fondaparinux | |||||||||||||
Medical condition: heart failure patients (III-IV NYHA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003219-77 | Sponsor Protocol Number: 2012-003219-77 | Start Date*: 2012-12-20 | |||||||||||
Sponsor Name:Copenhagen University Hospital, Rigshospitalet | |||||||||||||
Full Title: Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002688-31 | Sponsor Protocol Number: ICOR-2022-04-LEVOMEMS | Start Date*: 2023-01-25 | ||||||||||||||||||||||||||
Sponsor Name:Germans Trias i Pujol Health Research Institute | ||||||||||||||||||||||||||||
Full Title: LEVO-MEMS: COMPARISION OF THE HAEMODINAMIC PROFILE OF DOBUTAMIN AND LEVOSIMENDAN IN THE CURRENT THERAPEUTICAL CONTEXT | ||||||||||||||||||||||||||||
Medical condition: Heart failure patients with depressed left ventricular ejection fraction | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002090-12 | Sponsor Protocol Number: Ilocard | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Hospital of the university of munich | |||||||||||||
Full Title: Effect of Iloprost inhalation before and during extracorporeal circulation (ECC) on perioperative morbidity and outcome in high risk cardiac surgical patients | |||||||||||||
Medical condition: In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003111-28 | Sponsor Protocol Number: REPO-HFpEF-II | Start Date*: 2023-02-15 | |||||||||||
Sponsor Name:Hospital Clínico Universitario de Valencia | |||||||||||||
Full Title: Mechanism-based drug REpurPOsing in a subtype of Heart Failure with Preserved Ejection Fraction (REPO-HFPEF) | |||||||||||||
Medical condition: Subtype of Heart Failure with Preserved Ejection Fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021263-33 | Sponsor Protocol Number: 3001101 | Start Date*: 2011-05-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Sykehuset i Vestfold HF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: PERIOPERATIVE LEVOSIMENDAN INFUSION IN PATIENTS WITH HEART FAILURE UNDERGOING NON-CARDIAC SURGERY: A PROSPECTIVE, RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with serious cardiac failure scheduled for non-cardiac surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003273-42 | Sponsor Protocol Number: 14AOI11 | Start Date*: 2014-12-23 | |||||||||||
Sponsor Name:CHU de Nice | |||||||||||||
Full Title: Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
Medical condition: acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000622-22 | Sponsor Protocol Number: ASAP | Start Date*: 2012-07-20 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation | |||||||||||||
Medical condition: Placental insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001613-33 | Sponsor Protocol Number: BRIDGE | Start Date*: 2014-05-13 | ||||||||||||||||
Sponsor Name:Thoraxclinic at the University of Heidelberg | ||||||||||||||||||
Full Title: Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure | ||||||||||||||||||
Medical condition: Pulmonary Hypertension and Left Heart Failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-005077-39 | Sponsor Protocol Number: BBLOQ-2017 | Start Date*: 2018-06-12 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria INCLIVA | |||||||||||||
Full Title: Betablockers Withdrawal in Patients with Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Effect on Functional Capacity and life quality | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003822-96 | Sponsor Protocol Number: AC-055G201 | Start Date*: 2014-05-08 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||||||||||||||||||
Full Title: A prospective, multicenter, double-blind, randomized, placebo-controlled, parallel group, 12-week study to evaluate the safety and tolerability of macitentan in subjects with combined pre- and post... | ||||||||||||||||||
Medical condition: Combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left ventricular dysfunction. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) CZ (Completed) AT (Completed) BE (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003719-37 | Sponsor Protocol Number: GN15CA580 | Start Date*: 2017-07-25 | ||||||||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | ||||||||||||||||||
Full Title: StUdies of empaGliflozin and its cArdiovascular, Renal and metabolic effects in patients with Diabetes Mellitus (or prediabetes) and Heart Failure (SUGAR-DM-HF) | ||||||||||||||||||
Medical condition: Chronic heart failure with left ventricular systolic dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001916-69 | Sponsor Protocol Number: CF201101 | Start Date*: 2012-05-22 |
Sponsor Name:HagaZiekenhuis, pulmonary department | ||
Full Title: insulin therapy in non-diabetic adults with cystic fibrosis | ||
Medical condition: cystic fibrosis patients without cystic fibrosis related diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001710-32 | Sponsor Protocol Number: 2006-101 | Start Date*: 2006-07-05 |
Sponsor Name:Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet | ||
Full Title: PeRioperative OXygen fraction – effect on surgical site Infection and pulmonary complications after abdominal surgery. (The PROXI-study) | ||
Medical condition: Laparotomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.